ATE495252T1 - Neuartige phagenanzeigetechnologien - Google Patents
Neuartige phagenanzeigetechnologienInfo
- Publication number
- ATE495252T1 ATE495252T1 AT06795080T AT06795080T ATE495252T1 AT E495252 T1 ATE495252 T1 AT E495252T1 AT 06795080 T AT06795080 T AT 06795080T AT 06795080 T AT06795080 T AT 06795080T AT E495252 T1 ATE495252 T1 AT E495252T1
- Authority
- AT
- Austria
- Prior art keywords
- phage
- phage display
- display technologies
- novel phage
- protein
- Prior art date
Links
- 238000005516 engineering process Methods 0.000 title abstract 2
- 238000002823 phage display Methods 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 101710132601 Capsid protein Proteins 0.000 abstract 1
- 101710094648 Coat protein Proteins 0.000 abstract 1
- 241000724791 Filamentous phage Species 0.000 abstract 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 abstract 1
- 101710125418 Major capsid protein Proteins 0.000 abstract 1
- 101710141454 Nucleoprotein Proteins 0.000 abstract 1
- 101710083689 Probable capsid protein Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2005007325 | 2005-07-07 | ||
| PCT/IB2006/001878 WO2007007154A2 (en) | 2005-07-07 | 2006-07-06 | Novel phage display technologies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE495252T1 true ATE495252T1 (de) | 2011-01-15 |
Family
ID=37547018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06795080T ATE495252T1 (de) | 2005-07-07 | 2006-07-06 | Neuartige phagenanzeigetechnologien |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7811973B2 (de) |
| EP (1) | EP1904634B1 (de) |
| JP (1) | JP2009500030A (de) |
| KR (1) | KR20080039869A (de) |
| CN (1) | CN101258243A (de) |
| AT (1) | ATE495252T1 (de) |
| AU (1) | AU2006267968B2 (de) |
| BR (1) | BRPI0612589A2 (de) |
| CA (1) | CA2614304A1 (de) |
| DE (1) | DE602006019598D1 (de) |
| IL (1) | IL188554A0 (de) |
| RU (1) | RU2008104610A (de) |
| WO (1) | WO2007007154A2 (de) |
| ZA (1) | ZA200800104B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0613593A2 (pt) * | 2005-07-08 | 2011-01-18 | Univ Zuerich | método de teste "phage display" filamentoso, vetor de fago ou de fagomìdeo e biblioteca de vetores de fago ou fagomìdeo |
| KR101123641B1 (ko) * | 2008-12-31 | 2012-03-20 | 키스트 유럽 에프게엠베하 | 검출 물질에 특이적으로 반응할 수 있는 분자 인지 물질이 진열된 박테리오파아지의 제조 방법 및 상기 제조 방법으로제조된 박테리오파아지를 미량 검출물을 검출하는데 활용하는 방법 및 상기 박테리오파아지를 이용한 질량 분석장치 |
| EP2210944A1 (de) * | 2009-01-22 | 2010-07-28 | ATG:biosynthetics GmbH | Verfahren zur Erzeugung von RNA- und (Poly)Peptid-Bibliotheken und ihre Verwendung |
| WO2011074941A1 (en) * | 2009-12-15 | 2011-06-23 | Universiti Malaya | A method of high throughput screening of inhibitors that inhibit interaction of an attachment protein to cell receptors using recombinant phage display |
| WO2013115425A1 (en) * | 2012-01-31 | 2013-08-08 | Scripps Korea Antibody Institute | Methods for screening an antibody by one-cycle panning |
| EP2825557B1 (de) | 2012-03-16 | 2017-06-28 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Manipuliertes lösliches monomeres fc |
| CN105247050B (zh) * | 2013-03-14 | 2020-06-16 | 天演药业 | 用于文库构建、亲和力结合剂筛选和其表达的整合系统 |
| US9493764B2 (en) | 2014-04-22 | 2016-11-15 | Korea Institute Of Science And Technology | Hybrid electronic sheets |
| US9226403B2 (en) * | 2014-04-22 | 2015-12-29 | Korea Institute Of Science And Technology | Hybrid electronic sheets |
| CN105177017B (zh) * | 2015-10-30 | 2020-06-02 | 中国人民解放军第三军医大学第一附属医院 | 抗多亚基因型hcv抗体基因r4-85及其应用 |
| CN105219780B (zh) * | 2015-10-30 | 2020-06-02 | 中国人民解放军第三军医大学第一附属医院 | 抗多亚基因型hcv抗体基因r3-19及其应用 |
| EP3433377A4 (de) | 2016-03-23 | 2019-08-28 | The General Hospital Corporation | Assays und verfahren zur detektion von udp-glucose |
| CA3048992A1 (en) | 2016-12-30 | 2018-07-05 | Quidel Corporation | Phage-mediated immunoassay and methods for determining susceptibility of bacteria to antibiotic or probiotic agents |
| KR101937883B1 (ko) * | 2017-04-04 | 2019-01-14 | 한국과학기술연구원 | 바이오 물질을 포함하는 바인더 조성물 |
| JP7254071B2 (ja) | 2017-10-02 | 2023-04-07 | クイデル コーポレーション | 細菌種の抗菌薬感受性試験及び同定のためのファージに基づく検出方法 |
| EP3774926A1 (de) * | 2018-04-05 | 2021-02-17 | Bio-Rad ABD Serotec GmbH | Anzeigesysteme für proteine von interesse |
| CN111798712B (zh) * | 2020-07-15 | 2021-10-29 | 周晓庆 | 噬菌体侵染细菌3d智能模拟方法 |
| CN115109794A (zh) * | 2022-06-30 | 2022-09-27 | 武汉生之源生物科技股份有限公司 | 一种噬菌粒载体及其制备方法和应用 |
| CN116642877B (zh) * | 2023-06-01 | 2025-01-03 | 深圳市康百得生物科技有限公司 | 一种噬菌体生物发光阵列细菌检测芯片及其制备方法和应用 |
| CN119144569A (zh) * | 2024-11-20 | 2024-12-17 | 浙江大学 | 一种双展示噬菌体及其构建方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002258721A1 (en) * | 2001-04-05 | 2002-10-21 | Ramot At Tel Aviv University | Phage display vector, phages encoded thereby, and methods of use thereof |
| EP1373527A1 (de) * | 2001-04-06 | 2004-01-02 | CropDesign N.V. | Die verwendung doppelter und gegensätzlicher rekombinations-seiten für die 'single-step' klonierung zweier dna segmente |
| WO2003072773A1 (fr) | 2002-02-08 | 2003-09-04 | Seikagaku Corporation | Proteine fusionnee ayant une activite de glucuronyltransferase |
-
2006
- 2006-07-06 JP JP2008520018A patent/JP2009500030A/ja active Pending
- 2006-07-06 BR BRPI0612589-1A patent/BRPI0612589A2/pt not_active IP Right Cessation
- 2006-07-06 DE DE602006019598T patent/DE602006019598D1/de active Active
- 2006-07-06 CN CNA2006800323105A patent/CN101258243A/zh active Pending
- 2006-07-06 AT AT06795080T patent/ATE495252T1/de not_active IP Right Cessation
- 2006-07-06 ZA ZA200800104A patent/ZA200800104B/xx unknown
- 2006-07-06 AU AU2006267968A patent/AU2006267968B2/en not_active Ceased
- 2006-07-06 KR KR1020087000283A patent/KR20080039869A/ko not_active Withdrawn
- 2006-07-06 WO PCT/IB2006/001878 patent/WO2007007154A2/en not_active Ceased
- 2006-07-06 RU RU2008104610/13A patent/RU2008104610A/ru not_active Application Discontinuation
- 2006-07-06 US US11/994,820 patent/US7811973B2/en not_active Expired - Fee Related
- 2006-07-06 CA CA002614304A patent/CA2614304A1/en not_active Abandoned
- 2006-07-06 EP EP06795080A patent/EP1904634B1/de active Active
-
2008
- 2008-01-03 IL IL188554A patent/IL188554A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006019598D1 (de) | 2011-02-24 |
| EP1904634B1 (de) | 2011-01-12 |
| US20080312101A1 (en) | 2008-12-18 |
| BRPI0612589A2 (pt) | 2010-11-23 |
| EP1904634A2 (de) | 2008-04-02 |
| IL188554A0 (en) | 2008-04-13 |
| ZA200800104B (en) | 2009-08-26 |
| JP2009500030A (ja) | 2009-01-08 |
| WO2007007154A3 (en) | 2007-04-05 |
| AU2006267968B2 (en) | 2010-07-29 |
| CA2614304A1 (en) | 2007-01-18 |
| AU2006267968A1 (en) | 2007-01-18 |
| KR20080039869A (ko) | 2008-05-07 |
| US7811973B2 (en) | 2010-10-12 |
| CN101258243A (zh) | 2008-09-03 |
| RU2008104610A (ru) | 2009-08-20 |
| WO2007007154A2 (en) | 2007-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL188554A0 (en) | Novel phage display technologies | |
| Durani | Protein design with L-and D-α-amino acid structures as the alphabet | |
| EA201100669A1 (ru) | Биспецифичные молекулы, связывающие egfr/igfir | |
| CO6280541A2 (es) | Anticuerpos monoclonales o fragmentos del mismo que se unen al recptor humano ox40 | |
| CY1122195T1 (el) | Πολυπεπτιδια συντηξης σερπινης και μεθοδοι χρησης αυτων | |
| IL191852A (en) | Antibodies directed to her-3 and uses thereof | |
| CR11374A (es) | Proteinas humanas de union a antigenos del gm-csf | |
| WO2016179518A8 (en) | Prostate specific membrane antigen (psma) bispecific binding agents and uses thereof | |
| JP2015519344A5 (de) | ||
| AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
| DE60335000D1 (de) | In vitro peptid-expressionsbank | |
| WO2010033229A3 (en) | Methods and vectors for display of 2g12 -derived domain exchanged antibodies | |
| UA92154C2 (ru) | Rage-слитые белки и способы их применения | |
| Sugiyama et al. | Spatial arrangement and functional role of α subunits of proteasome activator PA28 in hetero-oligomeric form | |
| WO2010033237A3 (en) | Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules | |
| EA200801174A1 (ru) | Антитела-миметики glp-2, полипептиды, композиции, способы и применения | |
| JP2011004734A5 (de) | ||
| CL2009001284A1 (es) | Anticuerpos o fragmentos de union a antigeno del mismo que se unen a il-21r; composicion farmaceutica que lo comprende; acidos nucleicos codificantes; vectores de expresion y celulas huesped aisladas; kit de diagnostico que comprende a dichos anticuerpos | |
| Morimoto et al. | Synthesis of a large library of macrocyclic peptides containing multiple and diverse N-alkylated residues | |
| EA202091713A1 (ru) | Биологический синтез аминокислотных цепей для получения пептидов и белков | |
| Cusano et al. | Integration of binding peptide selection and multifunctional particles as tool-box for capture of soluble proteins in serum | |
| Ven Chang et al. | Screening for concanavalin A binders from a mannose-modified α-helix peptide phage library | |
| Mandrika et al. | Proteochemometric modelling of antibody–antigen interactions using SPOT synthesised peptide arrays | |
| ATE466874T1 (de) | Mit scytovirin der domäne 1 verwandte polypeptide | |
| ATE452994T1 (de) | In situ protein mikroarray zusammenbau |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |